These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16172574)

  • 1. Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma.
    Pace L; Catalano L; Del Vecchio S; De Renzo A; Fonti R; Salvatore B; Andretta C; Di Nuzzo C; Rotoli B; Salvatore M
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):281-5. PubMed ID: 16172574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma.
    Fonti R; Del Vecchio S; Zannetti A; De Renzo A; Catalano L; Pace L; Rotoli B; Salvatore M
    Cancer Biother Radiopharm; 2004 Apr; 19(2):165-70. PubMed ID: 15186596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
    Pace L; Catalano L; Pinto A; De Renzo A; Di Gennaro F; Califano C; Del Vecchio S; Rotoli B; Salvatore M
    Eur J Nucl Med; 1998 Jul; 25(7):714-20. PubMed ID: 9662593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
    Myslivecek M; Nekula J; Bacovsky J; Scudla V; Koranda P; Kaminek M
    Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
    Fallahi B; Beiki D; Mousavi SA; Gholamrezanezhad A; Eftekhari M; Fard-Esfahani A; Alimoghaddam K; Mirpour S; Eskandarian A; Saghari M
    Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
    Mele A; Offidani M; Visani G; Marconi M; Cambioli F; Nonni M; Catarini M; Brianzoni E; Berbellini A; Ascoli G; Brunori M; Agostini V; Corvatta L; Isidori A; Spinelli A; Gradari M; Leoni P
    Br J Haematol; 2007 Mar; 136(5):729-35. PubMed ID: 17233770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of 99mTc-MIBI whole body scintigraphy in active and in remission multiple myeloma.
    Fallahi B; Saghari M; Fard Esfahani A; Eftekhari M; Iravani M; Beiki D; Dabbagh Kakhki VR; Sadeghi R
    Hell J Nucl Med; 2005; 8(3):165-8. PubMed ID: 16390023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi.
    Castellani M; Carletto M; Baldini L; Calori R; Longari V; Soligo D; Dellavedova L; Gerundini P
    Clin Nucl Med; 2010 Jan; 35(1):1-5. PubMed ID: 20026963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
    J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
    Villa G; Balleari E; Carletto M; Grosso M; Clavio M; Piccardo A; Rebella L; Tommasi L; Morbelli S; Peschiera F; Gobbi M; Ghio R
    J Exp Clin Cancer Res; 2005 Sep; 24(3):355-61. PubMed ID: 16270521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
    Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
    Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
    Pace L; Catalano L; Del Vecchio S; Di Gennaro F; De Renzo A; Sica G; Califano C; Tedesco N; Borrelli G; Rotoli B; Salvatore M
    Eur J Nucl Med; 2001 Mar; 28(3):304-12. PubMed ID: 11315597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
    Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
    J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
    Fonti R; Del Vecchio S; Zannetti A; De Renzo A; Di Gennaro F; Catalano L; Califano C; Pace L; Rotoli B; Salvatore M
    Eur J Nucl Med; 2001 Feb; 28(2):214-20. PubMed ID: 11303893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
    Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
    Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
    Alper E; Gurel M; Evrensel T; Ozkocaman V; Akbunar T; Demiray M
    Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
    Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB
    Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of the accuracy of retention and washout measurements of 99mTc-Sestamibi from breast tumours using an anthropomorphic phantom.
    Marshall C; Griffiths PA
    Phys Med Biol; 2005 May; 50(9):2113-26. PubMed ID: 15843740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
    Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
    J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.